Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

Completed

Conditions studied: Inflammation, Uveitis

In brief

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants

Key facts

Study ID

NCT01060787

Run by

Bausch & Lomb Incorporated

People needed

98

Starts

2016-02-04

Expected to finish

2019-06-07

Last updated by the study team

2019-06-21

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Had the FA intravitreal implant (0.59 or 2.1 mg) in only one eye for at least one(1) year
• Able and willing to follow instructions
• Able and willing to provide informed consent

You may not qualify if…

• Is monocular
• Has current or relevant medical history that would interfere with their participation in this study, based on the judgment of the Investigator
• Had bilateral FA intravitreal implants
• Has a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study

Where it is running

• Ophthalmic Partners of Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.